These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2018-002117-36||A Phase IIa Exploratory 2-stage Design Study of CriPec® docetaxel Monotherapy in Subjects with Platinum Resistant Ovarian Cancer.||2020-07-06||due-trials|